There’s never been a better time to Buy BC and support local growers, producers and the food we love right here in BC.
Explore Buy BC products

Skip to main content
Skip to main navigation
Accessibility Statement

Limited coverage criteria – brexpiprazole

Last updated on March 17, 2025

Special Authority requests can now be submitted online. It's simple and quick!

Learn more or log in

Return to Special Authority drug list

Generic name	brexpiprazole
Strength & form	0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg tablet

Special Authority criteria	Approval period
Patient-specific diagnosis identified as schizophrenia or other psychosis (not dementia-related) AND Treatment failure or intolerance to at least one other specified anti-psychotic agent	Indefinite

Special Authority criteria

Approval period

Patient-specific diagnosis identified as schizophrenia or other psychosis (not dementia-related)

AND

Treatment failure or intolerance to at least one other specified anti-psychotic agent

Indefinite

Practitioner exemptions

None

Special notes

Criteria applicable for all plans, including Plan G
Patients who meet schizophrenia diagnosis criteria requirements for brexpiprazole automatically receive coverage for aripiprazole, olanzapine and ziprasidone

Special Authority request form(s)

Log in to eForms
HLTH 5328 - General Special Authority request (PDF, 656KB)

Did you find what you were looking for?

The B.C. Public Service acknowledges the territories of First Nations around B.C. and is grateful to carry out our work on these lands. We acknowledge the rights, interests, priorities, and concerns of all Indigenous Peoples - First Nations, Métis, and Inuit - respecting and acknowledging their distinct cultures, histories, rights, laws, and governments.

More topics